Yorktown Management & Research Company’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-9,012
Closed -$280K 261
2020
Q2
$280K Buy
+9,012
New +$306K 0.25% 213
2019
Q2
Sell
-52,700
Closed -$2.12M 344
2019
Q1
$2.12M Hold
52,700
0.69% 29
2018
Q4
$2.18M Sell
52,700
-6,219
-11% -$258K 0.72% 28
2018
Q3
$2.46M Hold
58,919
0.72% 28
2018
Q2
$2.03M Hold
58,919
0.59% 35
2018
Q1
$1.98M Hold
58,919
0.59% 40
2017
Q4
$2.02M Buy
58,919
+20,553
+54% +$701K 0.58% 35
2017
Q3
$1.3M Hold
38,366
0.34% 49
2017
Q2
$1.22M Hold
38,366
0.39% 47
2017
Q1
$1.25M Hold
38,366
0.32% 66
2016
Q4
$1.18M Buy
+38,366
New +$1.17M 0.3% 64
2016
Q3
Sell
-6,219
Closed -$208K 318
2016
Q2
$208K Buy
+6,219
New +$198K 0.05% 271
2016
Q1
Sell
-79,999
Closed -$2.45M 402
2015
Q4
$2.45M Sell
79,999
-31,620
-28% -$995K 0.43% 68
2015
Q3
$3.33M Buy
111,619
+42,160
+61% +$1.35M 0.55% 48
2015
Q2
$2.21M Buy
69,459
+63,240
+1,017% +$2.06M 0.39% 74
2015
Q1
$205K Buy
+6,219
New +$198K 0.04% 433

Other funds holding PFE

Yorktown Management & Research Company's PFE Position: Q3 2020 in Review

Yorktown Management & Research Company sold out of Pfizer (PFE) in Q3 2020, closing a stake of 9,012 shares — an estimated $280K sold.

Yorktown Management & Research Company first reported a position in PFE in Q1 2015 and held it in 16 quarters. The position peaked at $3.33M in Q3 2015. 2,508 funds tracked by Wall St. Rank hold PFE as of Q3 2020.

  • Yorktown Management & Research Company reported no remaining Pfizer position as of Q3 2020 after selling out during the quarter.
  • Yorktown Management & Research Company sold 9,012 Pfizer shares in Q3 2020, an estimated $280K.
  • Yorktown Management & Research Company first reported a position in Pfizer in Q1 2015 and held it in 16 quarters.
  • Yorktown Management & Research Company's Pfizer position peaked at $3.33M in Q3 2015.
  • 2,508 funds tracked by Wall St. Rank held Pfizer as of Q3 2020.

Based on Yorktown Management & Research Company's 13F filing for Q3 2020, filed 6 Nov 2020.